Abstract
AbstractBackground and ObjectivesAcquired immunodeficiency syndrome is one of the most important diseases caused by human immunodeficiency virus. Understanding its molecular pathogenesis is essential to manage the disease at the population level. In this study, a quantitative analysis of plasma proteins was carried out in drug resistant and drug respondent patients using the SWATH-MS.MethodsSequential window acquisition of all theoretical mass spectra (SWATH-MS) is a prime technique to seek the key plasma proteins involved in virus replication and drug metabolism during therapy.ResultsIn total, 204 proteins were identified and quantified, 57 proteins were differentially expressed, 25 proteins were down regulated and 32 proteins were upregulated in drug resistant patients. Six proteins such as complement C4-A, immunoglobulin heavy variable 1-2, carboxylic ester hydrolase, fibulin-1, immunoglobulin lambda constant 7, secreted phosphoprotein 24 were statistically expressed in drug resistant patients compared to the drug respondent patients. Gene ontology study and protein-protein interaction networks were established in six statistically significant differentially expressed proteins of the drug resistant patients.Interpretation and ConclusionOur findings high lights the novel proteins that were differentially expressed in drug resistant patients. A label-free quantitative proteomics method for depleted human plasma samples by SWATH-MS that can be useful in plasma proteomics research in any biological system.
Publisher
Cold Spring Harbor Laboratory
Reference29 articles.
1. Protein Binding in Antiretroviral Therapies
2. SWATH-MS as a tool for biomarker discovery: From basic research to clinical applications
3. Ludwig C , Gillet L , Rosenberger G , Amon S , Collins BC , Aebersold R. Data[independent acquisition[based SWATH[MS for quantitative proteomics: a tutorial. Mol. Syst. Biol. 2018, 14:e8126.
4. Ethical guidelines for biomedical research on human participants. 2006, ICMR ;1–120.
5. NACO, Govt. of India, Antiretroviral Therapy Guidelines for HIV-Infected Adults and Adolescents Including Post-Exposure Prophylaxis, 2007:1–125.